Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 20, 2022

SELL
$0.79 - $1.59 $32,186 - $64,779
-40,742 Closed
0 $0
Q4 2021

Feb 16, 2022

SELL
$1.36 - $2.94 $14,252 - $30,811
-10,480 Reduced 20.46%
40,742 $55,000
Q3 2021

Nov 12, 2021

SELL
$2.97 - $4.84 $3,757 - $6,122
-1,265 Reduced 2.41%
51,222 $154,000
Q2 2021

Aug 12, 2021

BUY
$3.71 - $5.13 $33,067 - $45,723
8,913 Added 20.45%
52,487 $242,000
Q1 2021

May 03, 2021

BUY
$4.08 - $14.75 $2,578 - $9,322
632 Added 1.47%
43,574 $187,000
Q4 2020

Feb 12, 2021

BUY
$11.06 - $14.01 $68,925 - $87,310
6,232 Added 16.98%
42,942 $475,000
Q3 2020

Nov 09, 2020

SELL
$10.26 - $14.55 $76,693 - $108,761
-7,475 Reduced 16.92%
36,710 $444,000
Q2 2020

Aug 10, 2020

SELL
$7.11 - $13.76 $668 - $1,293
-94 Reduced 0.21%
44,185 $592,000
Q1 2020

May 15, 2020

BUY
$5.71 - $15.85 $17,038 - $47,296
2,984 Added 7.23%
44,279 $343,000
Q4 2019

Feb 14, 2020

BUY
$9.6 - $17.75 $86 - $159
9 Added 0.02%
41,295 $631,000
Q3 2019

Nov 12, 2019

BUY
$12.16 - $21.0 $47,168 - $81,459
3,879 Added 10.37%
41,286 $519,000
Q2 2019

Aug 14, 2019

BUY
$9.44 - $19.8 $67,996 - $142,619
7,203 Added 23.85%
37,407 $741,000
Q1 2019

May 13, 2019

BUY
$11.11 - $13.49 $27,963 - $33,954
2,517 Added 9.09%
30,204 $370,000
Q4 2018

Feb 14, 2019

SELL
$10.24 - $15.49 $22,691 - $34,325
-2,216 Reduced 7.41%
27,687 $352,000
Q3 2018

Nov 14, 2018

SELL
$15.53 - $19.97 $41,434 - $53,279
-2,668 Reduced 8.19%
29,903 $464,000
Q2 2018

Aug 14, 2018

BUY
$15.88 - $19.5 $488,865 - $600,307
30,785 Added 1723.68%
32,571 $608,000
Q1 2018

May 15, 2018

SELL
$13.53 - $17.47 $14,558 - $18,797
-1,076 Reduced 37.6%
1,786 $30,000
Q4 2017

Feb 08, 2018

BUY
$14.41 - $19.15 $20,548 - $27,307
1,426 Added 99.3%
2,862 $45,000
Q3 2017

Nov 14, 2017

BUY
$13.5 - $19.51 $19,386 - $28,016
1,436
1,436 $25,000

Others Institutions Holding ATNX

About Athenex, Inc.


  • Ticker ATNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 156,790,000
  • Market Cap $1.57M
  • Description
  • Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral paclitaxel and encequidar,...
More about ATNX
Track This Portfolio

Track Manufacturers Life Insurance Company, The Portfolio

Follow Manufacturers Life Insurance Company, The and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.